Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of telmisartan on metformin pharmacokinetics and pharmacodynamics
ChiCTR-IPR-14005491Phase 4Recruiting
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of telmisartan and metformin, sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: Plasma concentration of metformin, Plasma glucose and 1 more. Started Nov 2014; status: recruiting.
02
Drugs
telmisartanmetformin
Beyond the preview
Go deeper on ChiCTR-IPR-14005491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005491.